Anti-Brd4 antibody [EPR5150(2)]
Anti-Brd4 항체 [EPR5150(2)]
- 20ul selling size
- BOND RX™ Validated
- RabMAb
- Recombinant
- Lab Essentials
- KD Validated
- 각 태그의 뜻
5
(18 리뷰들)
|
(222 제품이 사용된 논문 )
Enhanced IHC validation data – Download the data
- detailed IHC expression profiling in normal and clinically relevant cancer FFPE TMAs – seminoma, colon and stomach
- protocols for BOND RX™ and Ventana DISCOVERY ULTRA
KO validated for confirmed specificity
Over 160 publications
Biophysical QC for unrivalled batch-batch consistency
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Immunohistochemical analysis of formalin fixed paraffin embedded human colon labelling Brd4 with ab128874 at a concentration of 1 µg/ml. The immunostaining was performed on a Leica Biosystems BOND® RX instrument with a Bond™ Polymer Refine Detection kit. Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution 2) for 20 mins. ab128874 Anti-Brd4 antibody [EPR5150(2)] was incubated for 30 mins at room temperature. Sections were counterstained with Hematoxylin. Image inset shows absence of staining in secondary antibody only control.
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Immunohistochemical analysis of formalin fixed paraffin embedded human colon labelling Brd4 with ab128874 at a concentration of 3 µg/ml. The immunostaining was performed on a Ventana DISCOVERY ULTRA (Roche Tissue Diagnostics) instrument with an OptiView DAB IHC Detection Kit. Heat mediated antigen retrieval was conducted for 32 mins at 100°C with ULTRA cell conditioning solution (CC1, pH 8.5). ab128874 Anti-Brd4 antibody [EPR5150(2)] was incubated at 37°C for 16 mins. Sections were counterstained with Hematoxylin II. Image inset shows absence of staining in secondary antibody only control.
- ICC/IF
PubMed
Immunocytochemistry/ Immunofluorescence - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Immunocytochemical analysis of HeLa cells showing co-localization of BRD4 using ab128874 at 1/500 dilution (red) with CDK9 (green) following infection with HSV-1. Cells were fixed with 4% paraformaldehyde (10 min at RT) and permeabilzed with 0.2% Triton X-100 (10 min). AlexaFluor®-conjugated secondary antibodies were used at 1/1000 dilution. The nuclear counter stain is DAPI 9blue).
From Figure 5b of Ren et al.
Reproduced under the Creative Commons Licence fromRen et al PLoS Pathog. 2016 Oct; 12(10) : e1005950. Published online 2016 Oct 20. doi : 10.1371/journal.ppat.1005950 PMID : 27764245
Ren et al PLoS Pathog. 2016 Oct; 12(10): e1005950. Published online 2016 Oct 20. doi: 10.1371/journal.ppat.1005950
- ICC/IF
AbReview32451****
Immunocytochemistry/ Immunofluorescence - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Unpurified ab128874 (1/500 dilution) staining Brd4 in HeLa cells from cervix adenocarcinoma) cells (green). Cells were fixed in paraformaldehyde permeabilized in 0.5% Triton X100/PBS and counterstained with DAPI in order to highlight the nucleus (red).
For further experimental details please refer to Abreview.
Image courtesy of an abreview submitted by Dr. Kirk McManus, Univ. of Manitoba/Cancer Care MICB, Canada
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Intracellular Flow Cytometry analysis of SW480 (Human colorectal adenocarcinoma epithelial cell) cells labeling Brd4 (red) with purified ab128874 at a 1/50 dilution (10μg/mL). Cells were fixed with 80% methanol and permeabilized with 0.1% Tween-20. A goat anti rabbit IgG (Alexa Fluorr®488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (Black) (ab172730). Blue (unlabeled control) - Cell without incubation with primary antibody and secondary antibody (Blue).
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Immunocytochemistry/Immunofluorescence analysis of HepG2 (Human liver cell line) cells labeling Brd4 with purified ab128874 at 1/100 dilution (Panel A). Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% Triton X-100. An Alexa Fluor® 488-conjugated goat anti-rabbit IgG (1/200 dilution) was used as the secondary antibody. DAPI (blue) was used as the nuclear counterstain(Panel B).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Unpurified ab128874 at 1/100 dilution staining Brd4 in human colon carcinoma tissue by Immunohistochemistry.
Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Different batches of ab128874 were tested on HeLa (Human cervix adenocarcinoma epithelial cell) lysate at 0.1 µg/ml. 15 µg of lysate was loaded in each lane. Bands observed at 152 kDa.
All lanes:
Western blot - Anti-Brd4 antibody [EPR5150(2)] (ab128874)
Predicted band size: 152 kDa
false
- WB
Supplier Data
Western blot - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Blocking and Diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Brd4 antibody [EPR5150(2)] (ab128874) at 1/200 dilution
All lanes:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg/mL
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 152 kDa
Observed band size: 152 kDa
false
- WB
Supplier Data
Western blot - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Blocking and Diluting buffer and concentration : 5% NFDM/TBST
All lanes:
Western blot - Anti-Brd4 antibody [EPR5150(2)] (ab128874) at 1/1000 dilution
All lanes:
HeLa (Human epithelial cell line from cervix adenocarcinoma) cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 152 kDa
Observed band size: 152 kDa
false
- WB
Lab
Western blot - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
This blot was produced using 4-20% SDS-PAGE containing 15 μg of 293T whole cell lysate per lane at 150V for 1hr before being transferred onto a 0.45 μm PVDF membrane at 75V for 1hr. The membrane was then blocked for 1hr using 5% NFDM/TBST, then incubated with ab128874 (1/1000) at room temperature for 1hr. After being washed three times in TBST, the membrane was incubated with Peroxidase conjugated goat anti-rabbit IgG (H+L) (ab97051) at 1/20,000 dilution for 1hr at room temperature. The membrane was washed three times again. Then the signal was developed using the ECL technique.
ab128874 was stored at a range of temperatures (+4°C, +22°C, +37°C) for 1 week before being tested in WB. The image shows the band intensity remains relatively constant across all storage temperatures, demonstrating that antibody activity is not affected under these conditions. This data was generated as part of a structured antibody stability study supporting Abcam’s transition from cold‑chain to ambient shipping.
All lanes:
Western blot - Anti-Brd4 antibody [EPR5150(2)] (ab128874) at 1/1000 dilution
All lanes:
293T Whole cell lysate at 15 µg with NDFM/TBST
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
false
Exposure time: 5s
- WB
Lab
Western blot - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
Western blot : Anti-Brd4 antibody [EPR5150(2)] ab128874 staining at 1/1000 dilution, shown in green; Anti-Calnexin antibody [CANX/1543] ab238078 loading control staining at 1/20,000 dilution, shown in magenta. A band was observed at 200 kDa for Brd4L and 100 kDa for Brd4S in Wild-type MCF7 with a diminished signal detected in CRISPR-Cas9 Edited MCF7 cells expressing a heterozygous Brd4 knockout. Nuclear fractions exhibit enriched Brd4 expression in MCF7 and HeLa cell lines. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% NFDM in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG 800CW and Goat anti-Mouse IgG 680RD at 1/20,000 dilution. Abbreviations : W – Whole cell lysate; N – Nuclear fraction lysate; WT – Wild-Type.
All lanes:
Western blot - Anti-Brd4 antibody [EPR5150(2)] (ab128874) at 1/1000 dilution
Lane 1:
Wild type MCF7 (Whole cell lysate)
Lane 2:
Wild type MCF7 (Nuclear fraction lysate)
Lane 3:
Heterozygous MCF7 (Wild type)
Lane 4:
Heterozygous MCF (Nuclear fraction lysate)
Lane 5:
HeLa (whole cell lysate)
Lane 6:
HeLa (Nuclear fraction lysate)
Secondary
Lanes 1 - 6:
Goat anti-Rabbit IgG 800CW at 1/20000 dilution
Lanes 1 - 6:
Goat anti-Mouse IgG 680RD at 1/20000 dilution
Observed band size: 100 kDa,200 kDa
false
- WB
Supplier Data
Western blot - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
All lanes:
Western blot - Anti-Brd4 antibody [EPR5150(2)] (ab128874) at 1/1000 dilution
All lanes:
NIH/3T3 (Mouse embryo fibroblast cell line) cell lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 152 kDa
Observed band size: 152 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-Brd4 antibody [EPR5150(2)] (AB128874)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
관련 conjugated 항체와 다양한 조성의 항체 (5)
-
Anti-Brd4 antibody [EPR5150(2)] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Brd4 antibody [EPR5150(2)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Brd4 antibody [EPR5150(2)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Brd4 antibody [EPR5150(2)]
-
HRP Anti-Brd4 antibody [EPR5150(2)]
Reactivity 정보
제품 세부 정보
Anti-Brd4 antibody [EPR5150(2)] (ab128874) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt (Intra), ICC/IF, IHC-P and WB.
Anti-Brd4 antibody [EPR5150(2)] (ab128874) was first used in a scientific publication in 2014 and has been cited over 163 times in peer reviewed journals. It's performance in Western Blot in human samples is trusted by the scientific community.
Abcam's high quality manufacturing and validation processes ensure Anti-Brd4 antibody [EPR5150(2)] (ab128874) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility.
The specificity of Anti-Brd4 antibody [EPR5150(2)] (ab128874) has been confirmed by Western Blot testing in Brd4 knockout Hap1 cells.
Anti-Brd4 antibody [EPR5150(2)] (ab128874) has 17 independent reviews from customers.
Anti-Brd4 antibody [EPR5150(2)] (ab128874) specifically detects Brd4 (UniProt ID: O60885; Molecular weight: 153kDa) and is sold in 100 µL and 1 mL selling sizes.
Conjugation-ready, carrier free format available for antibody clone EPR5150(2) - ab182446.
Antibody clone EPR5150(2) is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, HRP, Alexa Fluor® 594 (ab197606, ab197608, ab197609, ab207057).
Top cited antibody for this target with >200 citations. A highly specific BRD4 antibody, essential for studying bromodomain-containing protein 4, epigenetic regulation and chromatin remodeling. This antibody is crucial in cancer research, particularly in understanding BRD4's role in transcription regulation, chemoresistance and tumor progression and is widely used in studies of BRD4 inhibitors and BET proteins. Research has shown that BRD4 (and BET family proteins) may be promising therapeutic targets for various Myc-driven cancers, such as Burkitt's lymphoma and certain acute myeloid leukaemia's and is studied is a potential therapeutic target.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein influences various cellular activities by regulating transcriptional elongation of specific genes. BRD4 forms part of a complex with P-TEFb (Positive Transcription Elongation Factor b) which phosphorylates the C-terminal domain of RNA polymerase II facilitating transcription through chromatin. It binds to acetylated histones and non-histone proteins linking it to active transcription sites and contributing to the dynamic regulation of gene expression in response to cellular signals.
Pathways
BRD4 participates in key signaling networks like the NF-κB pathway and MYC signaling. It interacts with transcription factors and other proteins such as Cyclin T1 and CDK9 within the P-TEFb complex to regulate gene expression. BRD4 also collaborates with MYC a critical transcription factor regulating cell growth and proliferation to modulate pathways related to cellular growth and survival.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
- Download enhancedValidationDataWebsite|en
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (222)
Recent publications for all applications. Explore the 전체 목록and refine your search
Acta pharmaceutica Sinica. B 15:4945-4960 PubMed41049731
2025
Applications
Unspecified application
Species
Unspecified reactive species
NPJ precision oncology 9:305 PubMed40877429
2025
Applications
Unspecified application
Species
Unspecified reactive species
World journal of emergency medicine 16:340-347 PubMed40708746
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of traditional and complementary medicine 15:434-445 PubMed40677544
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 53: PubMed40613709
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4863 PubMed40419519
2025
Applications
Unspecified application
Species
Unspecified reactive species
Animal cells and systems 29:312-324 PubMed40353255
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:4226 PubMed40335477
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nucleic acids research 53: PubMed40298110
2025
Applications
Unspecified application
Species
Unspecified reactive species
Toxics 13: PubMed40278574
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com